Perimenopause pp 119-143 | Cite as

Clinical Signs of Gametogenic Failure in Women

  • Richard T. ScottJr.
Part of the Serono Symposia USA book series (SERONOSYMP)

Abstract

The ability of a woman to conceive in the absence of specific pathophysiologic changes in her reproductive system is termed her reproductive potential. This potential declines with age and has contributed to the substantial increase in the prevalence of infertility in the United States (1–9). Initially, the decline in reproductive potential may be manifested in subtle ways such as lower fecundity rates and longer mean durations for women to become pregnant. As the decline in reproductive potential progresses, fecundity rates decrease to the point where the incidence of infertility rises and increased numbers of patients present for clinical evaluation and treatment.

Keywords

Phene Citrate Expense Progesterone Smoke 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mosher WD, Pratt WF. Fecundity and infertility in the United States: incidence and trends. Fertil Steril 1991;56:192–3.PubMedGoogle Scholar
  2. 2.
    Greenhall E, Vessey M. The prevalence of subfertility: a review of the current confusion and a report of two new studies. Fertil Steril 1990;54:978–83.PubMedGoogle Scholar
  3. 3.
    Mosher WD, Pratt W. Fecundity and infertility in the United States, 1965–1988. Advance data from vital and health statistics, no. 192, Dec. 4,1990. Hyattsville, MD: National Center for Health Statistics, 1990.Google Scholar
  4. 4.
    U.S. Congress, Office of Technology Assessment. Infertility: medical and social choices. Washington, DC: US Government Printing Office, 1988, OTA-BA-358.Google Scholar
  5. 5.
    Guttmacher AF. Factors affecting normal expectancy of conception. JAMA 1956;161:855–60.Google Scholar
  6. 6.
    Maroulis GB. Effect of aging on fertility and pregnancy. Semin Reprod Endocrinol 1991;9:165–75.CrossRefGoogle Scholar
  7. 7.
    Hollander D, Breen JL. Pregnancy in the older gravida: How old is old? Obstet Gyencol Surv 1990;45:106–12.CrossRefGoogle Scholar
  8. 8.
    Spira A. The decline of fecundity with age. Maturitas 1988;suppl 1:15–22.PubMedCrossRefGoogle Scholar
  9. 9.
    Henry L. Some data on natural fertility. Eugenics Q 1961;8:81–92.Google Scholar
  10. 10.
    Navot D, Drews MR, Bergh PA, et al. Age related decline in female fertility is not due to diminished capacity of the uterus to sustain embryo implantation. Fertil Steril 1994;61:97–101.PubMedGoogle Scholar
  11. 11.
    Sauer MV, Paulson RJ, Lobo RA. A preliminary report on oocyte donation extending reproductive potential to women over 40. N Engl J Med 1990; 323:1157–60.PubMedCrossRefGoogle Scholar
  12. 12.
    McPherson JC, Costoff A, Mahesh VB. Effects of aging on the hypothalamic-hypophyseal-gonadal axis in female rats. Fertil Steril 1977;28:1365–70.PubMedGoogle Scholar
  13. 13.
    Penzia AS, Thompson IE, Alper MM, Oskowitz SP, Berger MJ. Successful use of gamete intrafallopian transfer does not reverse the decline in fertility in women over 40 years of age. Obstet Gynecol 1991;77:37–9.Google Scholar
  14. 14.
    Alexander SE, Aksel S, Hazelton JM, Yeoman RR, Gilmore SM. The effect of aging on hypothalamic function in oophorectomized women. Am J Obstet Gynecol 1990;162:446–9.PubMedGoogle Scholar
  15. 15.
    Weiland NG, Wise PM. Aging progressively decreases the densities and alters the diurnal rhythms of α-1-adrenergic receptors in selected hypothalamic regions. Endocrinology 1990;126:2392–97.PubMedCrossRefGoogle Scholar
  16. 16.
    Peng MT, Huang HH. Aging of hypothalamic-pituitary-ovarian function in the rat. Fertil Steril 1972;23:535–42.PubMedGoogle Scholar
  17. 17.
    Scott RT, Rosenwaks Z. Oocyte donation. In Sciarra JJ, ed. Obstetrics and gynecology, vol. 5. Philadelphia: JB Lippincott, 1990;5:100.Google Scholar
  18. 18.
    Rosenwaks Z. Donor eggs: their application to modern reproductive technologies. Fertil Steril 1987;47:895–909.PubMedGoogle Scholar
  19. 19.
    Rotsztejn DA, Asch RH. Effect of aging on assisted reproductive technologies (ART): experience from oocyte donation. Semin Reprod Endocrinol 1991; 9:272–9.CrossRefGoogle Scholar
  20. 20.
    Baker TG, Challoner S, Burgoyne PS. The number of oocytes and the rate of atresia in unilaterally ovariectomized mice up to 8 months after surgery. J Reprod Fertil 1980;60:449–56.PubMedCrossRefGoogle Scholar
  21. 21.
    Richardson SJ, Senikas V, Nelson JF. Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987;65:1231–7.PubMedCrossRefGoogle Scholar
  22. 22.
    Federation CECOS, Schwartz D, Mayaux BA. Female fecundity as a function of age: results of artificial insemination in 2193 nulliparous women with azoospermic husbands. N Engl J Med 1982;306:404–6.CrossRefGoogle Scholar
  23. 23.
    Virro MR, Shewuck AB. Pregnancy outcome in 242 conceptions after artificial insemination with donor sperm and effects of maternal age on the prognosis for succesful pregnancy. Am J Obstet Gynecol 1984;148:518–24.PubMedGoogle Scholar
  24. 24.
    Lee SJ, Lenton EA, Sexton L, Cooke ID. The effect of age on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum Reprod 1988;7:851–5.Google Scholar
  25. 25.
    Rosenwaks Z, Muasher SJ. spiRecruitment of fertilizable eggs. In: Jones HW Jr, Jones GE, Hodgen GD, Rosenwaks Z, eds. Baltimore: Williams & Wilkins, 1986:30–52.Google Scholar
  26. 26.
    Ben-Rafael Z, Feldberg D. The poor responder patient in an in vitro fertilization-embryo transfer program. J Assist Reprod Genet 1993;10:118–20.PubMedCrossRefGoogle Scholar
  27. 27.
    Muasher SJ. Controversies in assisted reproduction: treatment of low responded. J Assist Repród Genet 1993;10:112–4.PubMedCrossRefGoogle Scholar
  28. 28.
    Olivennes F, Fanchin R, De Ziegler D, Frydman R. “Poor responders”: screening and treatment possibilities. J Assist Reprod Genet 1993;10:115–7.PubMedCrossRefGoogle Scholar
  29. 29.
    Piette C, de Mouzon J, Bachelot A, Spira A. In vitro fertilization: influence of woman’s age on pregnancy rates. Hum Reprod 1990;5:56–9.PubMedGoogle Scholar
  30. 30.
    Jacobs SL, Metzger DA, Dodson WC, Haney AF. Effect of age on response to human menopausal gonadotropin stimulation. J Clin Endocrinol Metab 1990;71:1525–30.PubMedCrossRefGoogle Scholar
  31. 31.
    Scott RT, Toner JF, Muasher SJ, Oehninger SC, Robinson S, Rosenwaks Z. Follicle stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989;51:651–4.PubMedGoogle Scholar
  32. 32.
    Toner JP, Philput CB, Jones GS, Muasher SJ. Basal follicle stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril 1991;55:784–91.PubMedGoogle Scholar
  33. 33.
    Pearlstone AC, Fournet N, Gambone JC, Pang SC, Buyalos RP. Ovulation induction in women age 40 and older: the importance of basal follicle-stimulating hormone level and chronological age. Fertil Steril 1992;58:674–9.PubMedGoogle Scholar
  34. 34.
    Cameron IT, O’Shea FC, Rolland JM, Hughes EG, de Kretser DM, Healy DL. Occult ovarian failure: A syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations. J Clin Endocrinol Metab 1988; 67:1190–4.PubMedCrossRefGoogle Scholar
  35. 35.
    Sherman BM, West JH, Korenman SG. The menopausal transition: analysis of LH, FSH, estradiol, and progesterone concentrations durmg menstrual cycles of older women. J Clin Endocrinol Metab 1976;42:629–36.PubMedCrossRefGoogle Scholar
  36. 36.
    Sherman BM, Korenman SG. Hormonal characteristics of the human menstrual cycle throughout reproductive Ufe. J Clin Invest 1975;55:699–706.PubMedCrossRefGoogle Scholar
  37. 37.
    Adamopoulos DA Loraine JA, Dove GA. Endocrinological studies in women approaching the menopause. J Obstet Gynecol Br Common 1971;78:62–79.CrossRefGoogle Scholar
  38. 38.
    Reyes FI, Winter JSD, Faiman C. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels. Am J Obstet Gynecol 1977;129:557–64.PubMedGoogle Scholar
  39. 39.
    Lenton EA, Sexton L, Lee S, Cooke ID. Progressive changes in LH and FSH and LH:FSH ratio in women throughout reproductive life. Maturitas 1988; 10:35–43.PubMedCrossRefGoogle Scholar
  40. 40.
    Metcalf MG, Livesey JH. Gonadotrophin excretion in fertile women: effect of age and the onset of the menopausal transition. J Endocr 1985;105:357–62.PubMedCrossRefGoogle Scholar
  41. 41.
    Muasher SJ, Oehninger S, Simonetti S, et al. The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril 1988;50:298–307.PubMedGoogle Scholar
  42. 42.
    Hughes EG, Robertson DM, Handelsman DJ, Hayward S, Healy DL, De-Kretser DM. Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome. J Clin Endocrinol Metab 1990;70:358–64.PubMedCrossRefGoogle Scholar
  43. 43.
    McClachlan RI, Healy DL, Robertson DM, DeKretser DM, Burger HG. Plasma inhibin levels during gonadotropin induced ovarian hyperstimulation for IVF: a new index of follicular function? Lancet 1986;1:1233–4.CrossRefGoogle Scholar
  44. 44.
    Seifer DB, Gardiner AC, Haning RV Jr, Rubin LP, Peluso JJ. Abstract 0–161. 41st Annual Meeting of the Society for Gynecologic Investigation, Chicago, IL, 1994.Google Scholar
  45. 45.
    Seifer DB, Guidice LC, Dsupin BA, Haning RV, Jr, Frishman GN, Burger HG. Abstract 0–162, 41st Annual Meeting of the Society for Gynecologic Investigation, Chicago, IL, 1994.Google Scholar
  46. 46.
    Scott RT, Hofmann GE, Oehninger S, Muasher SJ. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization. Fertil Steril 1990;297–302.Google Scholar
  47. 47.
    Khalifa E, Toner JP, Muasher SJ, Acosta AA. Significance of basal follicle-stimulating hormone levels in women with one ovary in a program of in vitro fertilization. Fertil Steril 1992;57:835–9.PubMedGoogle Scholar
  48. 48.
    Licciardi FL, Liu HC, Rosenwaks Z. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 1995;64:991–4.PubMedGoogle Scholar
  49. 49.
    Smotrich DB, Widra EA, Gindoff PR, Levy MU, Hall JL, Stillman RJ. Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 1995;64:1136–40.PubMedGoogle Scholar
  50. 50.
    Mukherjee T, Cooperman AB, Rosen T, Sandler B, Bustillo M, Grunfeld L. Low day three LH in the presence of normal baseline FSH predicts a poor response to controlled ovarian hyperStimulation, O-020. Presented at the 51st Annual Meeting of the American Society for Reproductive Medicine, Seattle, WA, October 7–12, 1995.Google Scholar
  51. 51.
    Kreiner D, Itskovitz J, Droesch K, Navot D, Liu H-C, Rosenwaks Z. Serum follicle stimulating hormone inhibition is a marker for preovulatory oocytes in in-vitro fertilization. Hum Reprod 1989;4:381–3.PubMedGoogle Scholar
  52. 52.
    Navot D, Rosenwaks Z, Margalioth EJ. Prognostic assessment of female fecundity. Lancet 1989;2:645–7.Google Scholar
  53. 53.
    Loumaye E, Billion JM, Mine JM, Psalit I, Pensis M, Thomas K. Prediction of individual response to controlled ovarian hyperstimulation by means of a clomiphene citrate challenge test. Fertil Steril 1990;53:295–301.PubMedGoogle Scholar
  54. 54.
    Tanbo T, Dale PO, Abyholm T, Stokke KT. Follicle-stimulating hormone as a prognostic indicator in clomiphene citrate/human menopausal gonadotrophin-stimulated cycles for in vitro fertilization. Hum Reprod 1989;6:647–50.Google Scholar
  55. 55.
    Tanbo T, Dale PO, Ludne O, Norman N, Abyholm T. Prediction of response to controlled ovarian hyperstimulation: a comparison of basal and clomiphene citrate-stimulated follicle stimulating hormone levels. Fertil Steril 1990; 53:295–301.Google Scholar
  56. 56.
    Scott RT, Leonardi MR, Hofmann GE, Illions EH, Neal GS, Navot D. A prospective evaluation of clomiphene citrate challenge test screening in the general infertility population. Obstet Gynecol 1993;82:539–45.PubMedCrossRefGoogle Scholar
  57. 57.
    Nader S, Berkowitz AS. Use of the hormonal response to clomiphene citrate as an endocrinological indicator of ovarian aging. Hum Reprod 1991;6:931–3.PubMedGoogle Scholar
  58. 58.
    Sharara FI, Beatse SN, Leonardi MR, Navot D, Scott RT. Cigarette smoking accelerates the development of diminished ovarian reserve as evidenced by the clomiphene citrate challenge test (CCCT). Fertil Steril 1994;62:257–62.PubMedGoogle Scholar
  59. 59.
    Scott RT, Leonardi MR, Neal GS, Toner JP, Illions EH, Hofmann GE. Comparison of the relative predictive values of abnormal day 3 and day 10 FSH concentrations in the clomiphene citrate challenge test. Fertil Steril, in review.Google Scholar
  60. 60.
    Scott RT, Opsahl MS, Leonardi MR, Neal GS, Illions EH, Navot D. Life table analysis of cumulative pregnancy rates based on the results of ovarian reserve screening and patient age in a general infertility population. Fertil Steril, in review.Google Scholar
  61. 61.
    Scott RT, Dellinger CL, Leonardi MR, Illions EH, Hofmann GE, Navot D. Evaluation of the significance of a poor estradiol response during the clomiphene citrate challenge test. Fertil Steril 1993;60:242–6.PubMedGoogle Scholar
  62. 62.
    Winslow KL, Toner JP, Brzyski RG, Oehninger SC, Acosta AA, Muasher SJ. The gonadotropin-releasing hormone agonist stimulation test—a sensitive predictor of performance in the flare-up in vitro fertilization cycle. Fertil Steril 1991;56:711–7.PubMedGoogle Scholar
  63. 63.
    Padilla SL, Bayati J, Garcia JE. Prognostic value of the early serum estradiol response to leuprolide acetate in in vitro fertilization. Fertil Steril 1990; 53:288–94.PubMedGoogle Scholar
  64. 64.
    Garcia JE, Padilla SL, Bayati J, Baramki TA. Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization. Fertil Steril 1990;53:302–5.PubMedGoogle Scholar
  65. 65.
    Hershlag A, Lesser M, Montefusco D, et al. Interinstitutional variability of follicle-stimulating hormone and estradiol levels. Fertil Steril 1992;58:1123–6.PubMedGoogle Scholar
  66. 66.
    Seifer DB, Canick JA, Seltman HJ, Frishman GN, Berk CA. Abstract P368. 39th Annual Meeting of the Society for Gynecologic Investigation, San Antonio, TX, 1993.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1997

Authors and Affiliations

  • Richard T. ScottJr.

There are no affiliations available

Personalised recommendations